Agreement with BARDA on ZENEO® Midazolam

Date de parution
Sommaire ou résumé

BARDA places a firm order of $60m to CROSSJECT for initial procurement of ZENEO® Midazolam into the U.S. Strategic National Stockpile as soon as FDA Authorization is obtained


BARDA also financially supports the U.S. late-stage development and regulatory activities necessary to obtain FDA approval of ZENEO® Midazolam 10mg and a new pediatric dose ZENEO® Midazolam auto injector


BARDA has the option to procure additional ZENEO® Midazolam auto injectors from CROSSJECT